Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control
1 other identifier
interventional
35
1 country
1
Brief Summary
The project involve evaluation of a web-based nutrition education program and pilot-testing of a new smartphone app for real-time data logging to identify factors causing glycemic variability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 21, 2015
CompletedFirst Posted
Study publicly available on registry
September 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2021
CompletedSeptember 5, 2021
August 1, 2021
1.9 years
September 21, 2015
August 31, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
area under the curve (AUC) above target (> 180 mg/dL)
Amount of time spent above \>180 mg/dL on CGM Freestyle Libre readings
3 months
Study Arms (1)
Intervention - Educ Module and App
EXPERIMENTALParticipants in this arm to be given smartphone app ("Sugar Sleuth") and educational module.
Interventions
Educational module and use of smart phone app ("Sugar Sleuth")
Eligibility Criteria
You may qualify if:
- Individuals that satisfy all of the following conditions will be considered for participation:
- Must be between the ages of 25 - 75 years of age (inclusive)
- Type 1 diabetes diagnosis at least 1 year, treated with multiple daily injections or insulin pump.
- A1c 7.5-9.0%
You may not qualify if:
- Current or past use of real-time CGM for more than 2 months.
- Pregnancy (self-reported) or planning conception in next 6 months.
- History of disordered eating, actively trying to lose weight or planning to do so, BMI \> 30 kg/m2 (to limit participation by individuals who are actively trying to lose weight),
- Medical conditions or medications that would affect gastric emptying such as gastroparesis, bariatric surgery, medications such as pramlinitide, liraglutide or exenatide.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elena Toschi, MD
Joslin Diabetes Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2015
First Posted
September 22, 2015
Study Start
September 1, 2015
Primary Completion
August 1, 2017
Study Completion
January 22, 2021
Last Updated
September 5, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share